Zobrazeno 1 - 10
of 80
pro vyhledávání: '"B, Poulsen Nautrup"'
Publikováno v:
Research in Veterinary Science. 150:170-178
Porcine reproductive and respiratory syndrome virus (PRRSV) is currently one of the most economically important health challenges in the global swine industry. The primary aim of this study was to evaluate the overall efficacy of a modified live viru
Publikováno v:
Research in veterinary science. 131
The vaccine against gonadotropin releasing factor (GnRF), Improvac®, has recently emerged as an option for rearing market gilts up to heavier harvest weights. Improvac's® temporary suppression of the ovarian function and gonadal hormones results in
Publikováno v:
Research in Veterinary Science. 119:182-195
Meta-analysis was used to compare pigs immunocastrated (IC) with Improvac® versus physically castrated (PC) or entire male (EM) pigs. Performance and carcass data as most relevant for producers and packers were analyzed and the risk of boar taint wa
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
B Poulsen Nautrup, Hiltrud Liedgens
Publikováno v:
Value in Health. 22:S903-S904
Publikováno v:
Journal of Medical Economics. 18:746-761
To update an earlier evaluation estimating the cost-effectiveness of quadrivalent influenza vaccination (QIV) compared with trivalent influenza vaccination (TIV) in the adult population currently recommended for influenza vaccination in the UK (all p
Publikováno v:
Journal of Animal Science. 91:5868-5877
The goal of this study was to determine the clinical and economic impact of using tulathromycin as first line treatment for bovine respiratory disease (BRD) compared with other commonly used antimicrobials. Two decision trees were developed simulatin
Autor:
B. Poulsen Nautrup
Publikováno v:
Der Urologe. 50:1573-1577
The QALY (quality-adjusted life year) is often used in pharmacoeconomic evaluations. It combines the two dimensions 'quality of life' and 'life expectancy' into one index. Quality of life is expressed as a utility, corresponding to a value between 0
Autor:
Mohamed Neine, A von Krempelhuber, Anastassia Anastassopoulou, DA van Oorschot, Desmond Curran, B Poulsen Nautrup, S Lorenc, Lijoy Varghese
Publikováno v:
Value in Health. 21:S230